Tag Archives: hard

Discounting hit J&J's Xarelto hard. Can a new launch turn things around?

Competition and discounting are understandably plaguing Johnson & Johnson’s older drugs. But its cardiovascular blockbuster Xarelto is also on that list. The New Jersey drugmaker reported a 14.4% dip in fourth-quarter sales for the anticoagulant, which competes against Pfizer and Bristol-Myers Squibb’s hotshot Eliquis and Boehringer Ingelheim’s Pradaxa. J&J attributed the ding to U.S. discounting in the… Read More »

Nursing home safety data hard to find

(Reuters Health) – Nursing Home Compare, a web-based tool from the U.S. government that helps consumers look into the quality of nursing homes, falls short when it comes to rating safety, a new study suggests. Nursing Home Compare, on the Medicare.gov web site, lets users find and compare nursing homes certified by the U.S. Centers… Read More »